- July 9, 2020
2:00 pm - 5:00 pm
Sepsis: Across the Continuum of Care Webinar
Surviving COVID-19: The Path to Optimal Recovery
A webinar focusing on COVID-19 survivorship that will be held Thursday, July 9 at 2PM ET / 11AM PT!
Almost any type of infection can lead to sepsis. The virus, SARS-CoV-2, can cause severe COVID-19 disease and lead to viral sepsis. As we learn more about acute clinical care for patients with COVID-19, it is essential to understand the recovery phase to provide optimal patient care. Understanding the challenges of survivors of COVID-19 and viral sepsis will help improve long-term outcomes. In this webinar, learn about delirium, fear, and the ABCDEF Bundle related to COVID-19 and sepsis. Speakers will discuss the role of post-ICU clinics, related post-intensive care syndrome (PICS), ICU-acquired weakness (ICUAW) and physical disability. Cognitive and mental health are an important component of patient care throughout the continuum of care. |
|
|
Date: July 9, 2020
Time: 2PM EST / 11AM PST
Continuing Education Credits:
Nurses, earn CE contact hours for this webinar!
Sepsis Alliance is a provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Non-nurse attendees will receive a certificate of attendance for 1.0 contact hours.
Speakers:
E. Wesley Ely, MD, MPH
Professor of Medicine and Critical Care, Associate Director of Aging Research, VA GRECC
Vanderbilt University School of Medicine
Carla Sevin, MD
Director, The ICU Recovery Center at Vanderbilt Medical Director, Pulmonary Patient Care Center, Associate Professor of Medicine
Vanderbilt University School of Medicine
James C. Jackson, PsyD
Director of Long-Term Outcomes, ICU Recovery Center
Vanderbilt University School of M
If you can’t make the date, register anyway to receive a link to view the webinar after it airs live. |
|
|
Sepsis Alliance gratefully acknowledges the support provided for the Sepsis: Across the Continuum of Care webinar series by bioMérieux, Inc. |
|
|
edicine |
|
|
No comments yet.